Administrative Core

行政核心

基本信息

项目摘要

ADMINISTRATIVE CORE Abstract The administrative core will lead, manage, and support all activities of the Acquired Resistance to Therapy Network (ARTNet) Center for Pancreatic Cancer (ACPC). It will represent ACPC at the trans-ARTNet network activities, and in interactions with NCI. The ARTNet administrative core will be responsible for managing the activities of the synergistic research ACPC projects with scientific and technical expertise and resources in the areas of therapy resistance, signaling, metabolism, pancreatic cancer biology, organoid and mouse models, immune and non-immune stroma, and PDAC tissues for studying the acquired therapy resistance in cancer. The core leadership will provide expertise spanning the basic to translational spectrum, consistent with the overarching theme of ACPC, with track records of building and guiding large scientific teams to successfully advance fields in transformative ways. We will utilize strategic management with innovative approaches, including an educational component to bring new talent into the field, engage diverse teams to facilitate new ideas, leverage national talent pertinent to the proposed goals, engage university leadership in building support for cutting-edge science, and utilize dedicated university expertise to facilitate engagement with basic and translational research programs to grow ARTNet centric interests. The administrative core will provide support for personnel involved in the administration, coordination, communication, biostatistics, and bioinformatics to support the ARTNet activities within the center and campus, other ARTNet centers, ARTNet Coordinating Data and Management Center (CDMC) and National Cancer Institutes (NCI). The administrative core will also provide scientific oversight, result dissemination, budgetary oversight, and clerical functions associated with the overall research program in this ACPC application. The core will implement center-wide activities which include, developing new collaborations on the ACPC projects, organize annual retreat, support acquired cancer therapy resistance seminar speakers within various academic units, advocate for the next generation of scientists (graduate students, postdoctoral researchers, and junior faculty) in the ACPC member laboratories. Finally, the administrative core will represent ACPC on the ARTNet steering committee.
行政核心 摘要 行政核心将领导、管理和支持获得性耐药治疗的所有活动 胰腺癌中心(ACPC)。它将在trans-ARTNet网络中代表ACPC 活动,并与NCI互动。艺术培训网的行政核心将负责管理 ACPC项目的协同研究活动,具有科学和技术专门知识和资源, 治疗抗性、信号传导、代谢、胰腺癌生物学、类器官和小鼠模型领域, 免疫和非免疫基质,以及PDAC组织,用于研究癌症中的获得性治疗抗性。的 核心领导层将提供从基础到翻译的专业知识, ACPC的首要主题,具有建立和指导大型科学团队成功 以变革的方式推进领域。我们将以创新的方式利用战略管理, 包括教育部分,将新的人才引入该领域,让不同的团队参与进来, 想法,利用与拟议目标相关的国家人才,让大学领导层参与建设支持 尖端科学,并利用专门的大学专业知识,以促进与基础和 转化研究计划,以发展以ARTNet为中心的兴趣。行政核心将提供支持 对于参与管理、协调、沟通、生物统计学和生物信息学的人员, 支持中心和校园内的ARTNet活动,其他ARTNet中心,ARTNet协调数据 和管理中心(CDMC)和国家癌症研究所(NCI)。行政核心还将提供 科学监督,结果传播,预算监督和与整体相关的文书职能 在这个ACPC应用程序的研究计划。该核心将实施全中心范围的活动,其中包括, 在ACPC项目上开展新的合作,组织年度务虚会,支持获得性癌症治疗 在各个学术单位的阻力研讨会发言人,倡导下一代科学家 (研究生,博士后研究人员和初级教师)在ACPC成员实验室。最后 行政核心将在ARTNet指导委员会中代表ACPC。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pankaj Kumar Singh其他文献

Utilization of wastewater as nutrient media and biomass valorization in marine Chrysophytes- Chaetoceros and Isochrysis
废水作为营养介质的利用和海洋金藻植物-角毛藻和等鞭金藻的生物量增值
  • DOI:
    10.1016/j.ecmx.2020.100062
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Pankaj Kumar Singh;Raya Bhattacharjya;A. Saxena;Bharti Mishra;A. Tiwari
  • 通讯作者:
    A. Tiwari
Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer
  • DOI:
    10.1016/j.jconrel.2022.05.034
  • 发表时间:
    2022-08-01
  • 期刊:
  • 影响因子:
    11.500
  • 作者:
    Ujala Gupta;Brojendra Nath Saren;Kedar Khaparkhuntikar;Jitender Madan;Pankaj Kumar Singh
  • 通讯作者:
    Pankaj Kumar Singh
Hyperplasia of Cervical Spinous Process Presenting as Subcutaneous Mass
  • DOI:
    10.1007/s12098-013-1315-1
  • 发表时间:
    2013-12-22
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Kanwaljeet Garg;Guru Dutta Satyarthee;Chinmaya Dash;Pankaj Kumar Singh;Poodipedi Sarat Chandra;Bhawani Shankar Sharma
  • 通讯作者:
    Bhawani Shankar Sharma
Long Segment Bony Spur in Split Cord Malformation Type 1
  • DOI:
    10.1007/s12098-016-2244-6
  • 发表时间:
    2016-10-22
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Kanwaljeet Garg;Pankaj Kumar Singh;Shashank Sharad Kale;Bhawani Shankar Sharma
  • 通讯作者:
    Bhawani Shankar Sharma
Advancements in robot-assisted incremental sheet hydroforming: a comparative analysis of formability, mechanical properties, and surface finish for rhomboidal and conical frustums

Pankaj Kumar Singh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pankaj Kumar Singh', 18)}}的其他基金

Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
  • 批准号:
    10518247
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Pancreatic Cancer ARTNet Center
胰腺癌 ARTNet 中心
  • 批准号:
    10707504
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10518244
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Cancer Metabolism Core
癌症代谢核心
  • 批准号:
    10707540
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Pancreatic Cancer ARTNet Center
胰腺癌 ARTNet 中心
  • 批准号:
    10518243
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Cancer Metabolism Core
癌症代谢核心
  • 批准号:
    10518246
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Metabolic regulation of FOLFIRINOX acquired resistance in pancreatic cancer
FOLFIRINOX 在胰腺癌中获得性耐药的代谢调节
  • 批准号:
    10707541
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
胰腺癌转移和进展中的线粒体钙信号传导
  • 批准号:
    10363987
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
ME2 介导的胰腺癌肿瘤抑制的分子基础
  • 批准号:
    10671029
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
胰腺癌转移和进展中的线粒体钙信号传导
  • 批准号:
    10565949
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 30.72万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 30.72万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 30.72万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 30.72万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 30.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了